¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ : 2023-10-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ : 2023-10-14
±³À°ÀÏÀÚ : 2023-10-14
±³À°Àå¼Ò : ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ)

±³À°ÁÖÁ¦ : ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ÀÌ´ë¼­¿ïº´¿ø
´ã´çÀÚ : ±è°æ¹Î
¿¬¶ôó : 02-2650-5801  

À̸ÞÀÏ : 9a277@eumc.ac.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, º´¸®°ú, ÀÇ·á»çȸÇÐ

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 10:30~10:50 Fusion biopsy in EUMC ÀÌÈ¿Á¤(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 10:50~11:10 Diagnosis of prostate cancer using urine biomarkers ±èû¼ö(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 11:10~11:30 F18 Florastamin(PSMA) PET ÀÌÁö¿­(°¡Å縯´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 11:30~11:50 Use of Big Data and Artificial Intelligence in Healthcare ¿ìÁ¾ÇÊ(¼¼Á¾´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 11:50~12:10 Artificial Intelligence in medicine ±èÈÖ¿µ(¿¬¼¼´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 12:10~12:30 Artificial Intelligence in Urology ½ÅÅ¿µ(ÀÌÈ­¿©´ë)

½Ä»ç 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 12:30~13:30 Lunch ()

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 13:30~13:50 Radical cystectomy with orthotopic neobladder in EUMC ±è¸í¼ö(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 13:50~14:10 Perioperative chemotherapy in Muscle Invasive Bladder Cancer Á¶Á¤¹Î(ÀÌÈ­¿©´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 14:10~14:30 Micropapillary and plasmacytoid subtypes of urothelial carcinoma; focused on histology, molecular alteration and chemotherapy effect Á¤¼¼¿î(ÀÌÈ­¿©´ë)

ÈÞ½Ä 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 14:30~15:00 Coffee Break ()

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 15:00~15:20 Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1 Application of RNA trans-splicing ribozyme in urologic cancer. Takashi Kobayashi(Kyoto University, Japan)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 15:20~15:40 Is molecular subtyping of bladder cancer applicable in our clinical settings? Ryoichi Saito(Kyoto University, Japan)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 15:40~16:00 Application of RNA trans-splicing ribozyme in urologic cancer À̼º¿í(´Ü±¹´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÀÌ´ë¼­¿ïº´¿ø ÄÁº¥¼Ç¼¾ÅÍ ´ë°­´ç (ÁöÇÏ 2Ãþ) 16:00~16:20 Investigational research of lipid biomarkers in prostate cancer using tissue and urine samples Takayuki Goto(Kyoto University, Japan)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÌ´ëºñ´¢ÀÇÇаú Ãß°èÇмú´ëȸ : 2023-10-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ 2023 preceptorship : 2023-10-14
´ÙÀ½±Û ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ´ëÀå³»½Ã°æ¿¬±¸È¸ 2023³â ÈĹݱâ Áý´ãȸ : 2023-10-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 81 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 42 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 50 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 47 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 23 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 52 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 39 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 33 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷